La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), a clinical-stage investigational product to treat conditions characterized by iron overload, including hereditary hemochromatosis, beta thalassemia, sickle cell disease, myelodysplastic syndrome, and polycythemia vera. The company was founded in 1989 and is headquartered in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/12/2019 10:29 PDT] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($9.61) From $9.610 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/11/2019 12:04 PDT] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($9.57) From $9.570 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/10/2019 07:50 PDT] LJPC Expected to Trade Up After Bullish Patterns Develop
• [09/03/2019 07:58 PDT] LJPC Expected to Trade Up After Bullish Patterns Develop
• [08/30/2019 07:55 PDT] LJPC Expected to Trade Up After Bullish Patterns Develop
• [08/16/2019 10:29 PDT] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($8.38) From $8.380 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/16/2019 10:29 PDT] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($8.45) From $8.450 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/07/2019 07:58 PDT] LJPC Expected to Trade Up After Bullish Patterns Develop
• [07/29/2019 08:06 PDT] LJPC Expected to Trade Up After Bullish Patterns Develop